In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-10 of 10 for your search:
Drug:  vandetanib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-06-C-0063, NCI-P6680, NCT00293566

2.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 5 to 18
Sponsor: NCI
Protocol IDs: 070189, 07-C-0189, NCI-07-C-0189, NCT00514046

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: 090089, 09-C-0089, NCT00923247

4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-03090, ZENECA-6474IL/0003, NCT00059722

5.

Phase: Phase II
Type: Treatment
Status: Unknown
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0405022-01, ZENECA-D4200C00007, ZENECA-D4200C007A, NCT00093392

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 080020, 08-C-0020, NCI-08-C-0020, NCI-P07148, NCT00566995

7.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000638595, S0904, U10CA032102, SWOG-S0904, NCT00872989

8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 090222, 09-C-0222, NCT00995007

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: D4200C00006, UCLA-0208009, ZENECA-6474IL/0006, CDR0000269881, NCT00054093

10.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-08-C-0087, 08-C-0087, NCI-P7189, 8178, NCT00734890
New Search